Phenotypic Drug Screening for Dysferlinopathy Using Patient‐Derived Induced Pluripotent Stem Cells

Dysferlinopathy is a progressive muscle disorder that includes limb‐girdle muscular dystrophy type 2B and Miyoshi myopathy (MM). It is caused by mutations in the dysferlin (DYSF) gene, whose function is to reseal the muscular membrane. Treatment with proteasome inhibitor MG‐132 has been shown to inc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stem Cells Transl Med
Asıl Yazarlar: Kokubu, Yuko, Nagino, Tomoko, Sasa, Katsunori, Oikawa, Tatsuo, Miyake, Katsuya, Kume, Akiko, Fukuda, Mikiko, Fuse, Hiromitsu, Tozawa, Ryuichi, Sakurai, Hidetoshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2019
Konular:
Cell‐Based Drug Development, Screening, and Toxicology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766604/
https://ncbi.nlm.nih.gov/pubmed/31250983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0280
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller